Business · 1 sources covering this

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·1h ago
This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/8617c3272746950b2c08c48c46afff55bd052ec8"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit"></iframe>

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

How 1 sources are covering this

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

More from Business

Long-term unemployment is surging in the U.S. There are hidden costs for workers and the economy

Sen. Bill Cassidy signs onto brief calling 'anti-weaponization' fund a 'dire threat'

Oil prices fall 3% on report Trump reluctant to restart Iran war

Trump plans $700 million investment in coal plants and terminal

Reader

Trust & legal

Across the network